Ligand Pharmaceuticals, Inc. (LGND)
196.92
+0.38
(+0.19%)
USD |
NASDAQ |
Jan 15, 15:04
Ligand Pharmaceuticals SG&A Expense (TTM): 93.03M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.70B |
| Johnson & Johnson | 23.38B |
| Elanco Animal Health, Inc. | 1.392B |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| Krystal Biotech, Inc. | 136.75M |